| AMEFX | FAAIX | AMEFX / FAAIX | |
| Total Expense Ratio | 0.37 | 0.67 | 55% |
| Annual Report Gross Expense Ratio | 0.37 | 0.70 | 53% |
| Fund Existence | 17 years | 17 years | - |
| Gain YTD | 9.676 | 18.791 | 51% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 140B | 7.71B | 1,816% |
| Annual Yield % from dividends | 3.69 | 1.64 | 224% |
| Returns for 1 year | 8.96 | 14.03 | 64% |
| Returns for 3 years | 28.15 | 42.54 | 66% |
| Returns for 5 years | 29.21 | 32.92 | 89% |
| Returns for 10 years | 54.50 | 89.66 | 61% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MCYAX | 13.08 | 0.06 | +0.46% |
| NYLI Candriam Emerging Markets Eq Cl A | |||
| GMHPX | 11.96 | 0.05 | +0.42% |
| Goldman Sachs Rising Dividend Gr P | |||
| GSPAX | 18.38 | 0.05 | +0.27% |
| Goldman Sachs US Eq Div and Premium A | |||
| PABGX | 205.12 | 0.42 | +0.21% |
| T. Rowe Price Blue Chip Growth Advisor | |||
| NRIAX | 22.42 | 0.03 | +0.13% |
| Nuveen Real Asset Income A | |||